Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 11 to 20 of 25

TitlePrioritisation programmeDecisionDecision date
Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders [TS ID 11978]None selectedNot selected
Ferric maltol for treating iron deficiency anaemia in children and adolescents aged 1 month to 17 years TS ID 11994None selectedNot selected
Guselkumab for treating chronic plaque psoriasis in children aged 6 to 17 years [TSID12002]None selectedNot selected
Ivacaftor for treating cystic fibrosis with mutations in the CFTR gene in babies and children aged 1 to 3 months or weighing 3 kg to 24 kg [TSID11894]None selectedNot selected
Spineform Hemibridge endoscopic vertebral stapling to reduce curvature in the growing scoliotic spine in childrenNone selectedNot selected
Setmelanotide for treating obesity caused by a rare genetic disorder in children aged 2 to 5 [TSID11827]None selectedNot selected
Elexacaftor–tezacaftor–ivacaftor and ivacaftor for treating cystic fibrosis with at least 1 F508del mutation in the CFTR gene in children aged 2 to 5 [TSID10767]None selectedNot selected
Baricitinib for treating moderate to severe atopic dermatitis in children and young people aged 2 to 17 [TSID10639]None selectedNot selected
Subcutaneous belimumab for treating systemic lupus erythematosus in children aged 5 to 17 [TSID11828]None selectedNot selected
Dulaglutide for treating type 2 diabetes in children and young people [TSID10660]None selectedNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All